Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

24 Apr 2015
Change (% chg)

$-1.39 (-1.64%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for DHR.N


Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. Its research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 50 countries. It operates in five segments: Test & Measurement;... (more)


Beta: 1.15
Market Cap(Mil.): $58,936.89
Shares Outstanding(Mil.): 707.53
Dividend: 0.14
Yield (%): 0.65


  DHR.N Industry Sector
P/E (TTM): 23.07 25.01 28.29
EPS (TTM): 3.61 -- --
ROI: -- 11.03 5.18
ROE: -- 12.65 8.08
Search Stocks

Nobel Biocare confirms guidance, profit beats estimates

ZURICH, Nov 6 - Swiss dental implant maker Nobel Biocare, which has agreed to be bought by U.S. healthcare company Danaher, confirmed its full-year sales and profitability targets on Thursday as it posted quarterly profit that beat expectations.

06 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: Pechala's Reports
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks